Microneedle patches incorporating zinc-doped mesoporous silica nanoparticles loaded with betamethasone dipropionate for psoriasis treatment

J Nanobiotechnology. 2024 Nov 14;22(1):706. doi: 10.1186/s12951-024-02986-4.

Abstract

Treating psoriasis presents a major clinical challenge because of the limitations associated with traditional topical glucocorticoid therapy. This study introduced a drug delivery system utilizing zinc-doped mesoporous silica nanoparticle (Zn-MSN) and microneedle (MN), designed to enhance drug utilization for prolonged anti-inflammatory and anti-itch effects. The MN system facilitated the transdermal delivery of betamethasone dipropionate (BD), allowing its slow release. The BD@Zn-MSN-MN system promoted the polarization of macrophages towards the anti-inflammatory M2 phenotype, achieving superior anti-inflammatory effects compared to the clinically used BD cream. Additionally, this study demonstrated that BD@Zn-MSN-MN could further alleviate itching in psoriasis-afflicted mice by decreasing the excitability of the transient receptor potential vanilloid V1 (TRPV1) ion channel positive neurons and reducing the release of calcitonin gene-related peptide (CGRP) in the dorsal root ganglion (DRG). These findings offer new insights and effective therapeutic options for the future design of transdermal drug delivery for psoriasis.

Keywords: Betamethasone dipropionate; Itch; Mesoporous silica nanoparticle; Microneedle; Psoriasis.

MeSH terms

  • Administration, Cutaneous*
  • Animals
  • Anti-Inflammatory Agents* / chemistry
  • Anti-Inflammatory Agents* / pharmacology
  • Betamethasone* / administration & dosage
  • Betamethasone* / analogs & derivatives
  • Betamethasone* / chemistry
  • Betamethasone* / pharmacokinetics
  • Betamethasone* / pharmacology
  • Drug Delivery Systems* / methods
  • Male
  • Mice
  • Nanoparticles* / chemistry
  • Needles
  • Porosity
  • Psoriasis* / drug therapy
  • RAW 264.7 Cells
  • Silicon Dioxide* / chemistry
  • Silicon Dioxide* / pharmacology
  • Zinc* / chemistry
  • Zinc* / pharmacology

Substances

  • Betamethasone
  • Silicon Dioxide
  • Zinc
  • betamethasone-17,21-dipropionate
  • Anti-Inflammatory Agents

Grants and funding